Induced neuronal activity does not attenuate amyloid beta-induced synaptic loss in vitro

Area of Science:

• Neuroscience
• Cell Biology
• Alzheimer's Disease Research

Background:

• Alzheimer's disease (AD) is characterized by amyloid beta (Aβ) accumulation, linked to synapse loss.
• Neuronal activity typically modulates synapse numbers, but its effect on Aβ-induced synapse loss is unclear.

Purpose of the Study:

• To investigate whether enhanced neuronal activity influences synapse loss caused by amyloid beta (Aβ) in primary hippocampal neuron cultures.
• To determine the role of neuronal activity in the context of Aβ pathology in Alzheimer's disease.

Main Methods:

• Primary hippocampal neurons from mouse pups were cultured.
• Neuronal activity was enhanced using designer receptors exclusively activated by designer drugs (DREADD).
• Neurons were treated with amyloid beta (Aβ), and synapse density was quantified via immunocytochemistry.

Main Results:

• Amyloid beta (Aβ) significantly decreased synapse density, likely by affecting postsynaptic structures.
• Enhanced neuronal activity alone did not significantly alter overall synapse density.
• A trend suggested that enhanced neuronal activity might increase presynapse density.

Conclusions:

• Enhanced neuronal activity does not prevent or mitigate amyloid beta (Aβ)-induced synapse loss in this in vitro model.
• The findings suggest that interventions targeting neuronal activity may not be sufficient to counteract Aβ-mediated synaptic damage in Alzheimer's disease.